Studying IL-17 inhibitors for hidden tendon inflammation in psoriasis
Part of Skin clinical trials.
This study tests whether IL-17 inhibitor medications can reduce inflammation in tendons and ligaments that is not visible on the skin but can be detected with a special ultrasound. It may be an option for people with moderate to severe psoriasis who have not had enough relief from creams or light therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older with plaque psoriasis (red, scaly patches on the skin).
- Your psoriasis is moderate to severe, or it affects your scalp or nails.
- An ultrasound shows signs of inflammation at the spots where tendons or ligaments attach to bone (usually in the feet or hands).
- Creams or light therapy have not controlled your psoriasis well enough.
- You do not have any other inflammatory joint disease, active infections (including tuberculosis), or serious medical problems like uncontrolled high blood pressure or liver/kidney issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This study uses power Doppler ultrasound to classify and measure how active your psoriatic arthritis is. It may help doctors better understand and treat your condition.
This trial studies people with psoriatic arthritis who have painful Achilles tendon insertion with signs of inflammation on ultrasound. It may help researchers better understand what drives tendon inflammation and how it can be treated.
This study uses special ultrasound imaging to look at the places where tendons attach to bone (called entheses) in people with psoriatic arthritis. The goal is to see how these images compare to those of healthy people, which may help doctors understand and monitor the condition better.
This study uses advanced testing to understand inflammation in people with certain chronic inflammatory diseases, such as psoriasis, psoriatic arthritis, other types of arthritis, or inflammatory bowel disease. The goal is to tailor treatment to your specific needs.
This study looks at what’s happening inside the body in people with plaque psoriasis who start certain biologic medicines that target the IL-23/IL-17 immune pathway. It may help explain why these treatments work and what body changes are linked to response.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.